Next, we examined the expression of CdGAP on a panel of radical prostatectomy specimens from 285 prostate cancer patients using the TF123 tissue microarray (TMA) series27 (Supplementary Fig. 6 and Supplementary Table 1). Here, ARHGAP31 is linked to prostate carcinoma.